PRKAA1 and arthritic joint disease: AMPK activation by specific AMPK agonist A-769662 suppressed inflammatory arthritis in murine models of antigen-induced arthritis (AIA) and passive K/BxN serum-induced arthritis, suggesting that targeted AMPK activation may be an effective therapeutic strategy for OA [46].